Fed. Circ. Urged To Reverse PTAB Ruling On Opiate Treatment
Reckitt Benckiser Pharmaceuticals Inc. asked a Federal Circuit panel on Wednesday to overturn a Patent Trial And Appeals Board decision that declared patent claims for the opiate addiction treatment Suboxone obvious,...To view the full article, register now.
Already a subscriber? Click here to view full article